A practical reference on reversed-phase HPLC: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-30. Anything still debated is marked as such rather than presented as settled.
Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.
Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.
The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
| Property | Value | Notes |
|---|---|---|
| Peptide sequence | Ala-Glu-Asp-Gly | Single-letter form AEDG |
| Compound class | Synthetic tetrapeptide | Not a natural free peptide |
| Research origin | Russian gerontology institutes | Developed during the 1990s |
| Main research claim | Telomerase activation | Evidence mainly from cultured cells |
| Regulatory status | Not an approved drug | Handled as a research material |
Verification of a sample usually begins with reversed-phase high-performance liquid chromatography, which resolves the peptide from truncated sequences and other impurities and expresses purity as a percentage of total peak area. Mass spectrometry by electrospray ionisation or matrix-assisted laser desorption supplies an independent check, because the measured mass can be compared against the theoretical value for AEDG. Amino acid analysis or tandem mass spectrometry sequencing can confirm residue order. Each of these methods answers a different question: a purity figure does not establish identity, and an identity match does not establish how much of the material is intact peptide.
The molecule is a short, linear, hydrophilic peptide that dissolves readily in water or aqueous buffer. Its principal chemical liabilities are hydrolytic rather than oxidative, since it contains no cysteine, methionine, or tryptophan residues. The aspartate–glycine step is a recognised site for aspartimide formation under mildly acidic or basic conditions, generating isoaspartate and succinimide-related products over time. Desiccated lyophilised powder held at −20 °C is comparatively stable, whereas dilute solutions degrade faster and are best frozen as single-use aliquots rather than thawed repeatedly.
Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.
Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.
Reported biological findings come mainly from cell culture and rodent experiments. Those studies describe changes in telomerase catalytic subunit expression, melatonin rhythm amplitude, and antioxidant enzyme activity after peptide exposure. Human data are sparse and consist of small trials with limited blinding and inconsistent endpoints. The proposed mechanisms remain hypotheses rather than established facts, and there is no consensus on whether effects observed in animals carry over to people. Independent replication outside the original research groups is limited, which is a recognised gap in the published literature.
The War Office has referred to several British government organisations throughout history, all relating to the army. It was a department of the British Government responsible for the administration of the British Army between 1857 and 1964, at which point its functions were transferred to the new Ministry of Defence (MoD). It was equivalent to the Admiralty at that time, which was responsible for the Royal Navy (RN), and (much later) the Air Ministry, which oversaw the Royal Air Force (RAF). The name 'Old War Office' is also given to the former home of the department, located at the junction of Horse Guards Avenue and Whitehall in central London. The landmark building was sold on 1 March 2016 by HM Government for more than £350 million, on a 250-year lease, for conversion into a luxury hotel and residential apartments. Prior to 1855, 'War Office' signified the office of the Secretary at War. In the 17th and 18th centuries, a number of independent offices and individuals were responsible for various aspects of Army administration. The most important were the Commander-in-Chief of the Forces, the Secretary at War, and the twin Secretaries of State; most of whose military responsibilities were passed to a new Secretary of State for War in 1794.
They can be fabricated without extreme temperatures or expensive "dry rooms". Their capacity is six times that of commercially available supercapacitors. The device reached volumetric capacitance of over 1,100 F/cm3. This corresponds to a specific capacitance of the constituent MnO2 of 1,145 F/g, close to the theoretical maximum of 1,380 F/g. Energy density varies between 22 and 42 Wh/L depending on device configuration. In May 2015 a boric acid-infused, laser-induced graphene supercapacitor tripled its areal energy density and increased its volumetric energy density 5-10 fold. The new devices proved stable over 12,000 charge-discharge cycles, retaining 90 percent of their capacitance. In stress tests, they survived 8,000 bending cycles.
Minor histocompatibility antigen (also known as MiHA) are peptides presented on the cellular surface of donated organs that are known to give an immunological response in some organ transplants. They cause problems of rejection less frequently than those of the major histocompatibility complex (MHC). Minor histocompatibility antigens (MiHAs) are diverse, short segments of proteins and are referred to as peptides. These peptides are normally around 9-12 amino acids in length and are bound to both the major histocompatibility complex (MHC) class I and class II proteins. Peptide sequences can differ among individuals and these differences arise from SNPs in the coding region of genes, gene deletions, frameshift mutations, or insertions. About a third of the characterized MiHAs come from the Y chromosome. Prior to becoming a short peptide sequence, the proteins expressed by these polymorphic or diverse genes need to be digested in the proteasome into shorter peptides. These endogenous or self peptides are then transported into the endoplasmic reticulum with a peptide transporter pump called TAP where they encounter and bind to the MHC class I molecule. This contrasts with MHC class II molecules's antigens which are peptides derived from phagocytosis/endocytosis and molecular degradation of non-self entities' proteins, usually by antigen-presenting cells. MiHA antigens are either ubiquitously expressed in most tissue like skin and intestines or restrictively expressed in the immune cells.
Lymph is circulated in the body via muscle contraction and drains into the lymphatic ducts, which empty into the subclavian veins, returning fluid into blood circulation. A lymph node is an organised collection of lymphoid tissue through which the lymph passes on its way back to the blood. Lymph nodes are particularly numerous in the mediastinum, neck, pelvis, axilla, and inguinal region. Gut-associated lymphoid tissue, including Peyer's patch, plays a major role in the immune system. The spleen produces immune cells to fight antigens in its white pulp, removes particulate matter and aged blood cells, mainly red blood cells in its red pulp, and produces blood cells during fetal life.
Sources: en.wikipedia.org
General Sir John French, General Officer Commanding the BEF, later wrote 'Without the assistance which the Territorials afforded between October 1914 and June 1915, it would have been impossible to hold the line in France and Belgium. Other Territorial formations were dispatched to Egypt and British India and other imperial garrisons, such as Gibraltar, thereby releasing regular units for service in France and enabling the formation of an additional five regular army divisions by early 1915. Territorial divisions went on to fight in all the major battles of the war in France and Belgium and several campaigns further afield including Gallipoli. (See main article Territorial Force). From 1916, as the war progressed, and casualties mounted, the distinctive character of territorial units was diluted by the inclusion of conscript and New Army drafts. Following the Armistice all units of the Territorial Force were gradually disbanded.
Selenocysteine (symbol Sec or U, in older publications also as Se-Cys) is the 21st proteinogenic amino acid. Selenoproteins contain selenocysteine residues. Selenocysteine is an analogue of the more common cysteine with selenium in place of the sulfur. Selenocysteine is present in several enzymes (for example glutathione peroxidases, tetraiodothyronine 5′ deiodinases, thioredoxin reductases, formate dehydrogenases, glycine reductases, selenophosphate synthetase 2, methionine-R-sulfoxide reductase B1 (SEPX1), and some hydrogenases). It occurs in all three domains of life, including important enzymes (listed above) present in humans. Selenocysteine was discovered in 1974 by biochemist Thressa Stadtman at the National Institutes of Health.
In molecular biology, immunophilins are a group of endogenous cytosolic peptidyl-prolyl isomerases (PPI), which catalyze the interconversion between the cis and trans isomers of peptide bonds containing the amino acid proline (Pro). They are chaperone molecules that generally assist in the proper folding of diverse "client" proteins. There are two families of immunophilins that are structurally unrelated, but have similar biochemical activity: cyclosporin-binding cyclophilins (CyPs) and FK506-binding proteins (FKBPs). In 2005, a group of dual-family immunophilins (DFI) has been discovered, mostly in unicellular organisms; these DFIs are natural chimera of CyP and FKBPs, fused in either order (CyP-FKBP or FKBP-CyP). Immunophilins are named as such because they were originally discovered in the context of immunosuppressive drugs; however both families of prolyl isomerases are ubiquitous across taxa and have diverse functions.
Sources: en.wikipedia.org
== 10 Honorary Degrees == 1962 - Catholic University of Chile 1970 - Chinese University of Hong Kong 1971 - (the year the synthesis of Human Growth Hormone was announced) University of the Pacific Marquette University Saint Peter's College 1977 - University of Uppsala, Sweden 1978 - University of San Francisco 1979 - Long Island University 1981 - University of Colorado 1982 - Medical College of Pennsylvania
Stoolmiller AC, Horwitz AL, Dorfman A (1972). "Biosynthesis of the chondroitin sulfate proteoglycan. Purification and properties of xylosyltransferase". J. Biol. Chem. 247 (11): 3525–32. doi:10.1016/S0021-9258(19)45172-7. PMID 5030630. Gotting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K (2000). "Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II". J. Mol. Biol. 304 (4): 517–28. doi:10.1006/jmbi.2000.4261. PMID 11099377.
=== Children's Congress and Kids in the House === Breakthrough T1D holds a biennial Children’s Congress, where over 150 children from the U.S. and the world between the ages of 4 and 17 meet with key decision-makers to share their experiences of life with T1D and raise awareness about the condition. In Australia, Breakthrough T1D advocates meet with members of parliament and key ministers at the Kids in The House event, held at Parliament House in election years. At Kids in the House in November 2024, Minister for Health and Aged Care, Hon Mark Butler MP, committed $50.1m to research by Breakthrough T1D; Shadow Minister for Health and Aged Care, Senator the Hon Anne Ruston, confirming a matched commitment.
== External operations == The Selous Scouts were involved in the Rhodesian military's attacks on insurgents and their bases in neighbouring countries, often known as external operations (or 'externals' for short). These operations became frequent from 1976. The unit's role in external operations included intelligence collection and directly attacking insurgents. In the intelligence gathering role, the Selous Scouts' Reconnaissance Troop conducted one or two man long-range reconnaissance patrols to locate or gather information on insurgent bases in Mozambique and Zambia. During direct attacks the Selous Scouts often impersonated soldiers of the country they were operating in. The Selous Scouts operated in eastern Botswana. This included fighting small actions against insurgents and a raid in which ZAPU leaders were captured in Francistown. The Selous Scouts also used pseudo tactics to collect intelligence in Francistown. Operation Long John was launched on 25 June 1976, against two guerilla bases located in Mozambique. This operation used 'flying column' tactics for the first time, which involved six vehicles manned by the Selous Scouts attacking the bases. Large quantities of munitions were destroyed, but few casualties were inflicted. On 9 August 1976, the Selous Scouts carried out Operation Eland, a raid on a ZANLA and FRELIMO controlled refugee camp at Nyadzonia in Mozambique. The Selous Scouts, who were mostly black and disguised in FRELIMO uniforms, included former Portuguese Army soldiers and a former ZANLA commander.
Sources: en.wikipedia.org
Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.
That question is not settled. Cell culture studies have reported increased telomerase activity after treatment, but comparable evidence from controlled human trials is lacking. Any claim about telomere lengthening in people should be treated as unproven.
It has not completed the large, controlled trials required for drug approval in major jurisdictions. Most human reports involve small samples and limited follow-up. As a result, it is sold as a research chemical rather than a licensed pharmaceutical product.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.